Orchestra BioMed holds R&D Day on AVIM Therapy; no new data disclosed

Orchestra BioMed Holdings, Inc.

R&D Day held June 11, 2024; presentation covers AVIM Therapy platform.
Presentation used at investor conferences; no new specific metrics or outcomes provided.
No changes to outlook, pipeline milestones, or capital structure announced.

item 7.01 item 9.01

Orchestra BioMed Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-24-070204

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.